CLINICAL STUDIES
A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran’s Hospital: a pilot study
Lynn Palacol Roppolo, MDa,
Robert Fitzgerald, PhDa,
Jennifer Dillow, BSa,
Thomas Ziegler, MDa,
Mitchell Rice, RNa and
Alan Maisel, MD, FACCa
a Division of Cardiology and Nephrology, Department of Medicine, and Department of Pathology, Veteran’s Affairs Medical Center and University of California, San Diego, California, USA
Manuscript received August 7, 1998;
revised manuscript received March 2, 1999,
accepted April 14, 1999.
Reprint requests and correspondence: Dr. Alan Maisel, VAMC, Cardiology 111-A, 3350 La Jolla Village Drive, San Diego, California 92161
amaisel{at}ucsd.edu
OBJECTIVES
The purpose of this study was to prospectively evaluate the usefulness of the cardiac troponins as predictors of subsequent cardiac events in patients with chronic renal failure undergoing dialysis.
BACKGROUND
Cardiac troponin T (cTnT) and I (cTnI) are cardiac markers that are specific for cardiac muscle. They are also excellent prognostic indicators for patients presenting with chest pain. Although cardiac disease is the leading cause of death in dialysis patients, standard methods to diagnose acute coronary syndromes in patients with renal failure are often misleading.
METHODS
A six-month prospective study was done in a university-affiliated Veterans Hospital’s dialysis clinic. Forty-nine patients undergoing chronic dialysis with no complaints of chest pain were followed for cardiac events occurring in the six months after cardiac troponin measurements. These included unstable angina, acute myocardial infarction and cardiac death. An additional 83 patients with renal failure but who were not undergoing dialysis were also examined.
RESULTS
Within six months all three dialysis patients with elevated cTnI at entry into the study suffered an adverse complication (specificity and positive predictive value = 100%). Twenty-five patients had cTnT elevated at >0.10 ng/ml (53%). Patients with diabetes were more likely to have elevated troponin T levels (64% vs. 25%, p = 0.01). All six patients developing cardiac events within three months had elevations of cTnT >0.1 ng/ml (sensitivity = 100%). Whereas the specificity of cTnT was only 56% for a near-term cardiac event, the negative predictive value of cTnT using a cutoff of  0.1 ng/ml was 100%. On restratifying patients using a cutoff value of cTnT of >0.2 ng/ml, only nine of 49 dialysis patients (18%) had elevated levels. In patients with renal failure not undergoing dialysis, only three of 83 (4%) had elevated troponin I or T. None of these patients suffered a cardiac event in the next six months.
CONCLUSIONS
This prospective pilot study clearly delineates the troponins as important prognosticators in asymptomatic otherwise "stable" patients on chronic dialysis, especially those with concomitant diabetes mellitus. It also appears that troponins are more likely to be elevated in dialysis patients than other patients with renal failure not on dialysis. The above suggests that the combination of cTnI and cTnT might be very effective in elucidating cardiac risks of patients with renal failure undergoing chronic dialysis.
|
Abbreviations and Acronyms
| | CK | = creatine kinase | | cTnI | = cardiac troponin I | | cTnT | = cardiac troponin T | | ECG | = electrocardiogram |
|
This article has been cited by other articles:
|
|
|
|
 
T. W. Wallace, S. M. Abdullah, M. H. Drazner, S. R. Das, A. Khera, D. K. McGuire, F. Wians, M. S. Sabatine, D. A. Morrow, and J. A. de Lemos
Prevalence and Determinants of Troponin T Elevation in the General Population
Circulation,
April 25, 2006;
113(16):
1958 - 1965.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Bozbas, A. Yildirir, and H. Muderrisoglu
Cardiac enzymes, renal failure and renal transplantation.
Clin. Med. Res.,
March 1, 2006;
4(1):
79 - 84.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Khan, B. R. Hemmelgarn, M. Tonelli, C. R. Thompson, and A. Levin
Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis
Circulation,
November 15, 2005;
112(20):
3088 - 3096.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Abbas, R. I. John, M. C. Webb, M. E. Kempson, A. N. Potter, C. P. Price, S. Vickery, and E. J. Lamb
Cardiac Troponins and Renal Function in Nondialysis Patients with Chronic Kidney Disease
Clin. Chem.,
November 1, 2005;
51(11):
2059 - 2066.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. deFilippi, S. Wasserman, S. Rosanio, E. Tiblier, H. Sperger, M. Tocchi, R. Christenson, B. Uretsky, M. Smiley, J. Gold, et al.
Cardiac Troponin T and C-Reactive Protein for Predicting Prognosis, Coronary Atherosclerosis, and Cardiomyopathy in Patients Undergoing Long-term Hemodialysis
JAMA,
July 16, 2003;
290(3):
353 - 359.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Lipshultz, M. J. G. Somers, S. R. Lipsitz, S. D. Colan, K. Jabs, and N. Rifai
Serum Cardiac Troponin and Subclinical Cardiac Status in Pediatric Chronic Renal Failure
Pediatrics,
July 1, 2003;
112(1):
79 - 86.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Beciani, A. Tedesco, A. Violante, S. Cipriani, M. Azzarito, A. Sturniolo, and G. Splendiani
Cardiac troponin I (2nd generation assay) in chronic haemodialysis patients: prevalence and prognostic value
Nephrol. Dial. Transplant.,
May 1, 2003;
18(5):
942 - 946.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Freda, W. H. W. Tang, F. Van Lente, W. F. Peacock, and G. S. Francis
Cardiac troponins in renal insufficiency: Review and clinical implications
J. Am. Coll. Cardiol.,
December 18, 2002;
40(12):
2065 - 2071.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Lowbeer, A. Gutierrez, S. A. Gustafsson, R. Norrman, J. Hulting, and A. Seeberger
Elevated cardiac troponin T in peritoneal dialysis patients is associated with CRP and predicts all-cause mortality and cardiac death
Nephrol. Dial. Transplant.,
December 1, 2002;
17(12):
2178 - 2183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. A. Khan, N. Wattanasuwan, N. J. Mehta, A. Tun, N. Singh, H. K. Singh, B. C. Vasavada, and T. J. Sacchi
Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: A two-year outcome analysis
J. Am. Coll. Cardiol.,
October 1, 2001;
38(4):
991 - 998.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Iliou, C. Fumeron, M. O. Benoit, P. Tuppin, C. L. Courvoisier, V. M. Calonge, N. Moatti, C. Buisson, and C. Jacquot
Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study
Nephrol. Dial. Transplant.,
July 1, 2001;
16(7):
1452 - 1458.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Ooi, D. Zimmerman, J. Graham, and G. A. Wells
Cardiac Troponin T Predicts Long-Term Outcomes in Hemodialysis Patients
Clin. Chem.,
March 1, 2001;
47(3):
412 - 417.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Stoffel, M. Pollok, C. A. Baldamus, J. C. Stolear, and D. Verbeden
Troponin I is a better prognostic parameter of cardiovascular events in asymptomatic patients on haemodialysis than troponin T
Nephrol. Dial. Transplant.,
August 1, 2000;
15(8):
1259 - 1260.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Ooi, P. A. Isotalo, and J. P. Veinot
Correlation of Antemortem Serum Creatine Kinase, Creatine Kinase-MB, Troponin I, and Troponin T with Cardiac Pathology
Clin. Chem.,
March 1, 2000;
46(3):
338 - 344.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Interpreting Elevated Troponin Levels in Dialysis Patients
Journal Watch (General),
August 17, 1999;
1999(817):
7 - 7.
[Full Text]
|
|
|
|
